From the Department of Anesthesiology and Pain Management, American University of Beirut Medical Center, Beirut, Lebanon.
Department of Anesthesiology, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon.
Anesth Analg. 2023 Jan 1;136(1):25-33. doi: 10.1213/ANE.0000000000005945. Epub 2022 Feb 25.
The removal of the laryngeal mask airway (LMA®) in children may be associated with respiratory adverse events. The rate of occurrence of these adverse events may be influenced by the type of anesthesia. Studies comparing total intravenous anesthesia (TIVA) with propofol and sevoflurane are limited with conflicting data whether propofol is associated with a lower incidence of respiratory events upon removal of LMA as compared to induction and maintenance with sevoflurane. We hypothesized that TIVA with propofol is superior to sevoflurane in providing optimal conditions and improved patient's safety during emergence.
In this prospective, randomized, double-blind clinical trial, children aged 6 months to 7 years old were enrolled in 1 of 2 groups: the TIVA group and the sevoflurane group. In both groups, patients were mechanically ventilated. At the end of the procedure, LMAs were removed when patients were physiologically and neurologically recovered to a degree to permit a safe, natural airway. The primary aim of this study was to compare the occurrence of at least 1 respiratory adverse event, the prevalence of individual respiratory adverse events, and the airway hyperreactivity score following emergence from anesthesia between the 2 groups. Secondary outcomes included ease of LMA insertion, quality of anesthesia during the maintenance phase, hemodynamic stability, time to LMA removal, and incidence of emergence agitation.
Children receiving TIVA with propofol had a significantly lower incidence (10.8.% vs 36.2%; relative risk, 0.29; 95% CI [0.14-0.64]; P = .001) and lower severity ( P = .01) of respiratory adverse outcomes compared to the patients receiving inhalational anesthesia with sevoflurane. There were no statistically significant differences in secondary outcomes between the 2 groups, except for emergence agitation that occurred more frequently in patients receiving sevoflurane ( P < .001).
Propofol induction and maintenance exerted a protective effect on healthy children with minimal risk factors for developing perioperative respiratory complications, as compared to sevoflurane.
喉罩气道(LMA®)的移除可能与呼吸不良事件有关。这些不良事件的发生率可能受到麻醉类型的影响。比较全凭静脉麻醉(TIVA)与丙泊酚和七氟醚的研究有限,且数据相互矛盾,即与七氟醚诱导和维持相比,丙泊酚是否与 LMA 移除时呼吸事件的发生率较低相关。我们假设 TIVA 与丙泊酚在提供最佳条件和改善患者苏醒期间的安全性方面优于七氟醚。
在这项前瞻性、随机、双盲临床试验中,6 个月至 7 岁的儿童被纳入以下 2 组之一:TIVA 组和七氟醚组。在这两组中,患者均进行机械通气。在手术结束时,当患者在生理和神经上恢复到允许安全、自然气道的程度时,即可移除 LMA。本研究的主要目的是比较两组患者在麻醉苏醒时至少发生 1 次呼吸不良事件的发生率、个别呼吸不良事件的发生率以及气道高反应性评分。次要结局包括 LMA 插入的难易程度、维持阶段麻醉的质量、血流动力学稳定性、LMA 移除时间和苏醒躁动的发生率。
与接受七氟醚吸入麻醉的患者相比,接受丙泊酚 TIVA 的患者呼吸不良事件的发生率(10.8%比 36.2%;相对风险,0.29;95%置信区间[0.14-0.64];P=.001)和严重程度(P=.01)显著降低。除了接受七氟醚的患者苏醒躁动更频繁(P<.001)外,两组患者的次要结局均无统计学差异。
与七氟醚相比,丙泊酚诱导和维持对具有最小围手术期呼吸并发症发生风险因素的健康儿童具有保护作用。